Related Experiment Video
Updated: Aug 29, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Pseudomembranous colitis caused by toxin A-negative/toxin B-positive variant strain of Clostridium difficile
Masahiro Toyokawa1, Akiko Ueda, Hisako Tsukamoto
1Laboratory for Clinical Investigation, Osaka University Hospital, Osaka University, 2-15 Yamadaoka, Suita, 565-0871 Osaka, Japan. toyokawa@hp-lab.med.osaka-u.ac.jp
Abstract:
We report the first case of pseudomembranous colitis (PMC) due to a toxin A-negative, toxin B-positive strain (toxin A variant strain) of Clostridium difficile in Japan. The toxin A variant strain of C. difficile is capable of causing PMC and is undetectable in clinical laboratories that use only toxin A immunoassays for C. difficile testing. If C. difficile-associated diarrhea is clinically suspected and toxin A is not detected, then the possibility of a toxin A variant strain should be considered, and further diagnostic testing, such as polymerase chain reaction (PCR) analysis for the detection of C. difficile toxin genes should be performed.
Insights
A new Clostridium difficile strain causing pseudomembranous colitis (PMC) was found in Japan. This toxin A-negative, toxin B-positive strain is missed by standard toxin A tests, requiring PCR for accurate diagnosis.
Area of Science:
- Microbiology
- Infectious Diseases
- Gastroenterology
Background:
- Clostridium difficile is a common cause of antibiotic-associated diarrhea and colitis.
- Pseudomembranous colitis (PMC) is a severe form of C. difficile infection.
- Current diagnostic methods primarily rely on detecting C. difficile toxins.
Observation:
- A case of PMC in Japan was caused by a novel strain of C. difficile.
- This strain was characterized as toxin A-negative and toxin B-positive, referred to as a toxin A variant strain.
- The patient presented with symptoms consistent with PMC.
Findings:
- The identified C. difficile toxin A variant strain is capable of causing PMC.
- Standard clinical laboratory immunoassays detecting only toxin A fail to identify this specific strain.
- This highlights a limitation in current diagnostic approaches for C. difficile infections.
Implications:
- Clinical laboratories using toxin A immunoassays may miss cases caused by this variant strain.
- Healthcare providers should consider the possibility of toxin A variant strains if C. difficile-associated diarrhea is suspected but toxin A is negative.
- Further diagnostic testing, such as polymerase chain reaction (PCR) for C. difficile toxin genes, is recommended for definitive diagnosis in such cases.
More Related Videos
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
12:58A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Related Concept Videos
Bacterial Gastroenteritis
Botulism
Bacterial Toxins
Diphtheria
Amebiasis
Cholera